i+Med is the owner of two patents related to the technologies to obtain these nanoparticles. Those patents summarize years of research in this area and i+Med applies them in the developments at the biomedical field. I+Med´s aim is that the society benefits from scientific advances. We therefore stand for the R+D+I to offer real solutions to the problems of people with a comprehensive, effective and efficient answer, prioritising the quality and effectiveness of our products. The discipline, commitment to improve all the processes, and the personal involvement, gives us an open mind to face new challenges and stay at the forefront of technology.